Cargando…
Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938203/ https://www.ncbi.nlm.nih.gov/pubmed/35459457 http://dx.doi.org/10.1016/j.neurol.2022.01.008 |
| _version_ | 1784672502110224384 |
|---|---|
| author | Bellakhdar, S. Maskaoui, J. Haddouali, K. El Moutawakil, B. Rafai, M.A. El Otmani, H. |
| author_facet | Bellakhdar, S. Maskaoui, J. Haddouali, K. El Moutawakil, B. Rafai, M.A. El Otmani, H. |
| author_sort | Bellakhdar, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8938203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89382032022-03-22 Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination Bellakhdar, S. Maskaoui, J. Haddouali, K. El Moutawakil, B. Rafai, M.A. El Otmani, H. Rev Neurol (Paris) Letter to the Editor Elsevier Masson SAS. 2022-06 2022-03-22 /pmc/articles/PMC8938203/ /pubmed/35459457 http://dx.doi.org/10.1016/j.neurol.2022.01.008 Text en © 2022 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Bellakhdar, S. Maskaoui, J. Haddouali, K. El Moutawakil, B. Rafai, M.A. El Otmani, H. Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination |
| title | Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination |
| title_full | Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination |
| title_fullStr | Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination |
| title_full_unstemmed | Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination |
| title_short | Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination |
| title_sort | myelin oligodendrocyte glycoprotein associated disorder following sars-cov-2 vaccination |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938203/ https://www.ncbi.nlm.nih.gov/pubmed/35459457 http://dx.doi.org/10.1016/j.neurol.2022.01.008 |
| work_keys_str_mv | AT bellakhdars myelinoligodendrocyteglycoproteinassociateddisorderfollowingsarscov2vaccination AT maskaouij myelinoligodendrocyteglycoproteinassociateddisorderfollowingsarscov2vaccination AT haddoualik myelinoligodendrocyteglycoproteinassociateddisorderfollowingsarscov2vaccination AT elmoutawakilb myelinoligodendrocyteglycoproteinassociateddisorderfollowingsarscov2vaccination AT rafaima myelinoligodendrocyteglycoproteinassociateddisorderfollowingsarscov2vaccination AT elotmanih myelinoligodendrocyteglycoproteinassociateddisorderfollowingsarscov2vaccination |